Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 550.12M P/E - EPS this Y -27.60% Ern Qtrly Grth -
Income -120.61M Forward P/E -2.80 EPS next Y 12.60% 50D Avg Chg -4.00%
Sales 96.41M PEG 0.27 EPS past 5Y - 200D Avg Chg -15.00%
Dividend N/A Price/Book 3.01 EPS next 5Y -10.70% 52W High Chg -51.00%
Recommedations 2.10 Quick Ratio 3.41 Shares Outstanding 96.38M 52W Low Chg 17.00%
Insider Own 8.76% ROA -13.13% Shares Float 80.28M Beta 0.82
Inst Own 89.58% ROE -66.65% Shares Shorted/Prior 7.54M/6.47M Price 6.60
Gross Margin -92.31% Profit Margin -125.11% Avg. Volume 503,085 Target Price 13.75
Oper. Margin -275.01% Earnings Date Aug 1 Volume 397,963 Change -4.49%
About Alector, Inc.

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

Alector, Inc. News
05/11/24 Here's Why We're Watching Alector's (NASDAQ:ALEC) Cash Burn Situation
05/09/24 Alector to Participate in Upcoming Healthcare Conferences
05/08/24 Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates
05/08/24 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
04/25/24 Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
04/11/24 The past five years for Alector (NASDAQ:ALEC) investors has not been profitable
03/01/24 The Alector, Inc. (NASDAQ:ALEC) Full-Year Results Are Out And Analysts Have Published New Forecasts
02/29/24 What You Need To Know About The Alector, Inc. (NASDAQ:ALEC) Analyst Downgrade Today
02/28/24 Q4 2023 Alector Inc Earnings Call
02/28/24 Alector, Inc. (NASDAQ:ALEC) Q4 2023 Earnings Call Transcript
02/27/24 Alector Inc (ALEC) Reports Fourth Quarter and Full Year 2023 Financial Results
02/27/24 Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
02/20/24 Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
02/20/24 Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline
02/08/24 Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
02/08/24 Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?
02/07/24 FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
02/01/24 With 67% institutional ownership, Alector, Inc. (NASDAQ:ALEC) is a favorite amongst the big guns
01/25/24 Alector (ALEC) Upgraded to Strong Buy: Here's What You Should Know
01/23/24 Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs
ALEC Chatroom

User Image epsguid Posted - 1 week ago

$ALEC reported a loss of $0.38, consensus was ($0.48) via @eWhispers #epsbeat http://eps.sh/d/alec

User Image Stock_Titan Posted - 1 week ago

$ALEC Alector Reports First Quarter 2024 Financial Results and Provides Business Update https://www.stocktitan.net/news/ALEC/alector-reports-first-quarter-2024-financial-results-and-provides-hdedecp84lz4.html

User Image Bugseason Posted - 1 week ago

$ITOS long $ITOS $RNA $BMEA $BLUE $ALEC let's goooooooo

User Image ElijahJobs Posted - 2 weeks ago

$ALEC Any AD P2 data release coming this year? THX

User Image demondaytrader Posted - 04/27/24

@demondaytrader $ALEC 90% institutional/ 96M Better than expected report Watching for onboarding below $4.83 with a rip into Q4 test results.

User Image TeenageMutantNinjaTrader Posted - 1 month ago

$ALEC anyone remember that idiot who called this a "timed" stock. What B's. No opinion on it otherwise. I just remember that

User Image Bigeyes2 Posted - 1 month ago

$ALEC

User Image techNICKaltrader Posted - 1 month ago

$ALEC swing idea stop 5.39 close, upside tgt 7.44 , 8,

User Image DailyStocksPicks Posted - 2 months ago

$CRBU experienced a stock decline after halting development on its CB-020 cell therapy, causing concern over its future and pipeline potential. The company reported a widened loss and decreased revenue for the quarter ending December 31, failing to meet analyst expectations due to increased R&D expenses. Despite the setback from pausing CB-020, Caribou's solid financial standing, including substantial cash reserves and a $25 million investment from Pfizer, indicates confidence in its remaining pipeline. The volatility in biotech investments, influenced by strategic decisions and market perceptions, highlights the importance of understanding the risks and opportunities in the sector. This situation underscores the speculative nature of investing in biotech, emphasizing careful consideration of a company's long-term potential and current challenges. $ALEC, $FATE, $EXAI, $CCCC For more details https://youtu.be/33j1fI9rhmk

User Image insiderbuyingselling Posted - 2 months ago

$ALEC new insider selling: 10169 shares. http://insiderbuyingselling.com/?t=ALEC

User Image Doozio Posted - 2 months ago

$ALEC chop chop huckleberries.. 🧠⏰

User Image Stock_Titan Posted - 02/28/24

$ALEC Alector to Participate in Upcoming Healthcare Conferences https://www.stocktitan.net/news/ALEC/alector-to-participate-in-upcoming-healthcare-t8db6th1ulit.html

User Image epsguid Posted - 02/27/24

$ALEC reported a loss of $0.49, consensus was ($0.80) via @eWhispers #epsbeat http://eps.sh/d/alec

User Image Stock_Titan Posted - 02/27/24

$ALEC Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update https://www.stocktitan.net/news/ALEC/alector-reports-fourth-quarter-and-full-year-2023-financial-results-0ufeh85a4wwh.html

User Image TickerDD_com Posted - 02/21/24

From 2/16/2024, looking back across 22 Month-Ends for ALEC, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had More Positives (95%) $ALEC #ALEC #ALECStock #TickerDD #ALECPrice https://www.youtube.com/watch?v=cgoHd6S6dtQ

User Image Stock_Titan Posted - 02/20/24

$ALEC Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call https://www.stocktitan.net/news/ALEC/alector-to-host-fourth-quarter-and-full-year-2023-earnings-nn4j9xy9z49e.html

User Image Bugseason Posted - 3 months ago

$ALEC slow and steady for the mid year results.

User Image StockInvest_us Posted - 3 months ago

Signal alert: $ALEC - Oversold Trend Short (Undervalued) https://stockinvest.us/l/cOBmzSlpf9

User Image Mr_Lieu Posted - 3 months ago

$ALEC

User Image SebastianColbourne Posted - 3 months ago

$ALEC $PNST $DNTH Analyst price target for today; https://live-alerts-stock-trades.daytrading.network

User Image Stock_Titan Posted - 3 months ago

$ALEC Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease https://www.stocktitan.net/news/ALEC/alector-announces-first-patient-dosed-in-progress-ad-phase-2-ek72gli3be9w.html

User Image Nandoarts Posted - 3 months ago

$ALEC

User Image Investor_99 Posted - 3 months ago

$ALEC Institutions holds about 73%. It is not retailers play. It will go up organically.

User Image FrankJosephjr Posted - 3 months ago

$ALEC Up only 2.6% ....on this news???

User Image sndbnd Posted - 3 months ago

$ALEC surprised we haven't seen volume yet. Maybe we'll start seeing halts with 10% movements. That's my speculation

User Image Investor_99 Posted - 3 months ago

$ALEC Except 200 moving average all of them are in Buy Zone. Waiting for 200 Moving average to cross.

User Image Investor_99 Posted - 3 months ago

$ALEC

User Image CL0WNsHalvingShort Posted - 3 months ago

$ALEC Lets go already......

User Image CL0WNsHalvingShort Posted - 3 months ago

$HOLO This was a nice gainer but $ALEC is still taking its time

User Image Nifty_Trader Posted - 3 months ago

$ALEC I’m ready. Hope you loaded up ✅ 🌋

Analyst Ratings
HC Wainwright & Co. Buy May 9, 24
Cantor Fitzgerald Overweight May 9, 24
HC Wainwright & Co. Buy Feb 28, 24
Stifel Buy Dec 14, 23
Deutsche Bank Buy Dec 12, 23
Mizuho Buy Nov 17, 23
Goldman Sachs Sell Sep 25, 23
Cantor Fitzgerald Overweight Sep 22, 23
Mizuho Buy Aug 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
GRASSO MARC Chief Financial Offi.. Chief Financial Officer Dec 04 Sell 5.56 4,574 25,431 150,673 12/06/23
Romano Gary Chief Medical Office.. Chief Medical Officer Dec 04 Sell 5.56 5,035 27,995 202,314 12/06/23
Rosenthal Arnon Chief Executive Offi.. Chief Executive Officer Dec 04 Sell 5.56 23,831 132,500 2,019,217 12/06/23
Kenkare-Mitra Sara President and Head o.. President and Head of R&D Dec 04 Sell 5.56 12,519 69,606 329,016 12/06/23
Rosenthal Arnon Chief Executive Offi.. Chief Executive Officer Sep 05 Sell 5.1945 5,647 29,333 1,645,448 09/06/23
Kenkare-Mitra Sara President and Head o.. President and Head of R&D Sep 05 Sell 5.1943 6,214 32,277 177,935 09/06/23
Romano Gary Chief Medical Office.. Chief Medical Officer Sep 05 Sell 5.1942 2,771 14,393 99,349 09/06/23
GRASSO MARC Chief Financial Offi.. Chief Financial Officer Sep 05 Sell 5.1943 1,114 5,786 32,247 09/06/23
Kenkare-Mitra Sara President and Head o.. President and Head of R&D Jun 02 Sell 6.9037 4,092 28,250 184,149 06/05/23
GRASSO MARC Chief Financial Offi.. Chief Financial Officer Jun 02 Sell 6.9037 1,050 7,249 33,361 06/05/23
Romano Gary Chief Medical Office.. Chief Medical Officer Jun 02 Sell 6.9037 2,617 18,067 102,120 06/05/23
Rosenthal Arnon Chief Executive Offi.. Chief Executive Officer Jun 02 Sell 6.9037 5,255 36,279 1,651,095 06/05/23
Rosenthal Arnon Chief Executive Offi.. Chief Executive Officer Mar 03 Sell 6.22 15,186 94,457 1,656,350 03/21/23
Romano Gary Chief Medical Office.. Chief Medical Officer Dec 02 Sell 8.51 5,383 45,809 104,737 03/03/23
Kenkare-Mitra Sara President and Head o.. President and Head of R&D Mar 02 Sell 8.3185 10,124 84,216 188,241 03/03/23
GRASSO MARC Chief Financial Offi.. Chief Financial Officer Mar 02 Sell 8.3184 1,291 10,739 34,411 03/03/23
Rosenthal Arnon Chief Executive Offi.. Chief Executive Officer Mar 02 Sell 8.3178 5,849 48,651 1,628,546 03/03/23
Yaffe Kristine Director Director Sep 10 Option 18.10 2,000 36,200 2,000 01/31/23
Romano Gary Chief Medical Office.. Chief Medical Officer Sep 02 Sell 10.6202 2,177 23,120 90,073 09/07/22
King Robert Chief Development Of.. Chief Development Officer Sep 02 Sell 10.6205 176 1,869 529,295 09/07/22
King Robert Chief Development Of.. Chief Development Officer Mar 01 Sell 15.5679 287 4,468 528,404 03/03/22
SULIMAN SHEHNAAZ President and COO President and COO Dec 10 Option 17.23 150,000 2,584,500 177,598 12/14/21
SULIMAN SHEHNAAZ President and COO President and COO Dec 10 Sell 21.73 150,000 3,259,500 102,598 12/14/21
SULIMAN SHEHNAAZ President and COO President and COO Dec 08 Option 14.9 150,000 2,235,000 177,598 12/10/21
SULIMAN SHEHNAAZ President and COO President and COO Dec 08 Sell 22.94 150,000 3,441,000 102,598 12/10/21
Rosenthal Arnon Chief Executive Offi.. Chief Executive Officer Nov 10 Sell 25 110,000 2,750,000 1,972,875 11/12/21
Rosenthal Arnon Chief Executive Offi.. Chief Executive Officer Nov 04 Sell 25 200,000 5,000,000 682,500 11/08/21
Paul Robert Chief Medical Office.. Chief Medical Officer Mar 10 Option 9.15 19,175 175,451 232,894 03/10/21
Paul Robert Chief Medical Office.. Chief Medical Officer Mar 10 Sell 18.12 19,175 347,451 213,719 03/10/21
Paul Robert Chief Medical Office.. Chief Medical Officer Feb 11 Option 9.15 19,175 175,451 232,894 02/11/21
Paul Robert Chief Medical Office.. Chief Medical Officer Feb 11 Sell 20.81 19,175 399,032 213,719 02/11/21
Paul Robert Chief Medical Office.. Chief Medical Officer Jan 27 Option 9.15 57,308 524,368 241,027 01/27/21
Paul Robert Chief Medical Office.. Chief Medical Officer Jan 27 Sell 18 57,308 1,031,544 213,719 01/27/21
Paul Robert Chief Medical Office.. Chief Medical Officer Jan 21 Option 9.15 38,567 352,888 222,286 01/21/21
Paul Robert Chief Medical Office.. Chief Medical Officer Jan 21 Sell 18.06 38,567 696,520 213,719 01/21/21